TWI748424B - Whitening essential oil composition and its use - Google Patents

Whitening essential oil composition and its use Download PDF

Info

Publication number
TWI748424B
TWI748424B TW109114049A TW109114049A TWI748424B TW I748424 B TWI748424 B TW I748424B TW 109114049 A TW109114049 A TW 109114049A TW 109114049 A TW109114049 A TW 109114049A TW I748424 B TWI748424 B TW I748424B
Authority
TW
Taiwan
Prior art keywords
essential oil
whitening
oil composition
present
agents
Prior art date
Application number
TW109114049A
Other languages
Chinese (zh)
Other versions
TW202139971A (en
Inventor
王曉芬
易光輝
呂佳樺
Original Assignee
弘光科技大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 弘光科技大學 filed Critical 弘光科技大學
Priority to TW109114049A priority Critical patent/TWI748424B/en
Publication of TW202139971A publication Critical patent/TW202139971A/en
Application granted granted Critical
Publication of TWI748424B publication Critical patent/TWI748424B/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

本發明揭示一種美白精油組成物,包含:台灣扁柏精油、紅檜精油、錫蘭肉桂精油、八角茴香精油,以及狹葉薰衣草精油。本發明亦揭示該美白精油組成物可被用來美白皮膚以及抑制黑色素生成。The present invention discloses a whitening essential oil composition comprising: Taiwan cypress essential oil, red juniper essential oil, Ceylon cinnamon essential oil, star anise essential oil, and anise lavender essential oil. The present invention also discloses that the whitening essential oil composition can be used to whiten skin and inhibit melanin production.

Description

美白精油組成物及其用途Whitening essential oil composition and its use

本發明是有關於一種美白精油組成物,特別是指一種用來美白皮膚以及抑制黑色素生成的精油組成物。 The present invention relates to a whitening essential oil composition, in particular to an essential oil composition used for whitening skin and inhibiting melanin production.

黑色素生成(melanogenesis)[亦即黑色素合成(melanin synthesis)]是指當皮膚黑色素細胞(dermal melanocyte)在受到環境因素[諸如紫外線(ultraviolet,UV)]或生理因素[諸如疲勞(fatigue)、壓力(stress)、慢性發炎(chronic inflammation)以及體內不正常的α-促黑素細胞素(α-melanocyte stimulating hormone,α-MSH)的釋放]的誘發之後,在黑色素細胞內的酪胺酸(tyrosine)經由酪胺酸酶(tyrosinase)的催化[它是黑色素生成的速率-限制步驟(rate-limiting step)]以及一系列的氧化還原反應而被轉化為黑色素(melanin)的過程。黑色素可以保護皮膚的下皮層(hypodermis)免於紫外線所造成的光損害(photodamage),但是當黑色素被大量地累積於皮膚上或不正常地分佈時可能會導致皮膚疾病(skin disorders),諸如雀斑 (lentigines)、斑點(freckle)、黑皮病(melasma)、老人斑(age spots)以及色素過多(hyperpigmentation)等。 Melanogenesis (also known as melanin synthesis) refers to when skin melanocytes (dermal melanocytes) are exposed to environmental factors (such as ultraviolet (UV)) or physiological factors (such as fatigue, stress ( After the induction of stress, chronic inflammation, and abnormal release of α-melanocyte stimulating hormone (α-MSH) in the body, tyrosine in melanocytes The process of being converted into melanin through the catalysis of tyrosinase [it is the rate-limiting step of melanin production] and a series of redox reactions. Melanin can protect the hypodermis of the skin from photodamage caused by ultraviolet rays. However, when melanin is accumulated on the skin in large amounts or is abnormally distributed, it may cause skin disorders, such as freckles. (lentigines), spots (freckle), melasma (melasma), age spots (age spots) and hyperpigmentation (hyperpigmentation) and so on.

為了達到皮膚美白(skin whitening)的目的,目前已有許多黑色素生成抑制劑(melanogenesis inhibitors)被使用來淡化或去除累積於皮膚上的黑色素或是黑斑,而這些黑色素生成抑制劑大多是經由抑制酪胺酸酶的活性、加速酪胺酸酶的降解(degradation),或是促進黑色素分解等機制來調控黑色素的生成。其中,已知可用於抑制酪胺酸酶活性的黑色素生成抑制劑包括對苯二酚(hydroquinone)、熊果苷(arbutin)以及麴酸(kojic acid)等。 In order to achieve the purpose of skin whitening, many melanogenesis inhibitors have been used to lighten or remove the accumulated melanin or dark spots on the skin. Most of these melanogenesis inhibitors are inhibited Mechanisms such as tyrosinase activity, acceleration of tyrosinase degradation, or promotion of melanin decomposition can regulate the production of melanin. Among them, melanin production inhibitors known to be useful for inhibiting tyrosinase activity include hydroquinone, arbutin, and kojic acid.

近年來,人類對於皮膚美白與保養的需求與日俱增,然而目前所使用的黑色素生成抑制劑在淡化或去除黑色素上的效果仍不盡理想。因此,本領域的相關研究人員皆嘗試從天然來源中尋找可供用於抑制黑色素生成的天然活性組分。例如,許多植物材料製得的萃取物或精油已被發現具有抑制黑色素生成的效用,該等植物包括:狹葉薰衣草(Lavandula angustifolia)、檸檬草(Cymbopogon citratus)、佛手柑(Citrus medica var.sarcodactylus)、丁香(Syzygium aromaticum)、錫蘭肉桂(Cinnamomum verum)、八角茴香(Illicium verum)、薑黃(Curcuma longa)、羅勒(Ocimum basilicum)、玫瑰(Rosa rugosa)、月見草屬物種(Oenothera spp.)、台灣扁柏 (Chamaecyparis obtusa var.formosana)(又稱黃檜)以及紅檜(Chamaecyparis formosensis)等。然而,上述的研究大多僅止於單方精油的試驗,較少有針對複方精油用於美白功能的研究。因此,找尋具有較佳美白功效的複方精油仍存有需求。 In recent years, human needs for skin whitening and maintenance have increased day by day. However, the melanin production inhibitors currently used are still not satisfactory in lightening or removing melanin. Therefore, relevant researchers in the field try to find natural active components that can be used to inhibit melanin production from natural sources. For example, extracts or essential oils made from many plant materials have been found to have the effect of inhibiting melanin production. These plants include: Lavandula angustifolia , Cymbopogon citratus , and Citrus medica var.sarcodactylus ), Clove ( Syzygium aromaticum ), Cinnamomum verum , Illicium verum , Curcuma longa , Ocimum basilicum , Rosa rugosa , Oenothera spp., Taiwan cypress ( Chamaecyparis obtusa var.formosana ) (also known as yellow cypress) and red cypress ( Chamaecyparis formosensis ) and so on. However, most of the above-mentioned studies are only limited to the trials of single essential oils, and there are few studies on the use of compound essential oils for whitening functions. Therefore, there is still a need to find compound essential oils with better whitening effects.

經研究,申請人意外地發現:一包含有台灣扁柏精油、紅檜精油、錫蘭肉桂精油、八角茴香精油以及狹葉薰衣草精油的組成物能夠更有效地抑制酪胺酸酶活性。因此,依據本發明的美白精油組成物被預期可供用於美白皮膚。 After research, the applicant unexpectedly found that a composition containing Taiwan cypress essential oil, red cypress essential oil, Ceylon cinnamon essential oil, star anise essential oil, and lavender essential oil can more effectively inhibit tyrosinase activity. Therefore, the whitening essential oil composition according to the present invention is expected to be useful for whitening skin.

本發明的第一目的在於提供一種美白精油組成物。 The first object of the present invention is to provide a whitening essential oil composition.

於是,本發明美白精油組成物包含:台灣扁柏精油、紅檜精油、錫蘭肉桂精油、八角茴香精油,以及狹葉薰衣草精油。 Therefore, the whitening essential oil composition of the present invention includes: Taiwan cypress essential oil, red juniper essential oil, Ceylon cinnamon essential oil, star anise essential oil, and lavender essential oil.

本發明第二目的在於提供一種如上所述之美白精油組成物供應用於製備一用來美白皮膚之醫藥品或化妝品的用途。 The second object of the present invention is to provide a use of the above-mentioned whitening essential oil composition for preparing a medicine or cosmetic for skin whitening.

本發明的功效在於:本發明美白精油組成物具備不錯的酪胺酸酶活性抑制率,可有效用於各種美白皮膚之醫藥品或化妝品。 The effect of the present invention is that the whitening essential oil composition of the present invention has a good inhibition rate of tyrosinase activity, and can be effectively used in various skin whitening medicines or cosmetics.

本發明的上述以及其它目的、特徵與優點,在參照以下的詳細說明後,將變得明顯。 The above and other objects, features, and advantages of the present invention will become apparent with reference to the following detailed description.

本發明美白精油組成物包含:台灣扁柏精油、紅檜精油、錫蘭肉桂精油、八角茴香精油,以及狹葉薰衣草精油。 The whitening essential oil composition of the present invention includes: Taiwan cypress essential oil, red cypress essential oil, Ceylon cinnamon essential oil, star anise essential oil, and anise lavender essential oil.

在本發明美白精油組成物中,台灣扁柏精油、紅檜精油、錫蘭肉桂精油、八角茴香精油,以及狹葉薰衣草精油是藉由將台灣扁柏(Chamaecyparis obtusa var.formosana)的木材、紅檜(Chamaecyparis formosensis)的木材、錫蘭肉桂(Cinnamomum verum)的樹皮、八角茴香(Illicium verum)的果實,以及狹葉薰衣草(Lavandula angustifolia)的花分別予以蒸餾萃取而得到。 In the whitening essential oil composition of the present invention, Taiwan cypress essential oil, red cypress essential oil, Ceylon cinnamon essential oil, star anise essential oil, and anise lavender essential oil are obtained by combining the wood and red cypress (Chamaecyparis obtusa var. formosana) of Taiwan cypress (Chamaecyparis obtusa var. formosana). The wood of Chamaecyparis formosensis , the bark of Cinnamomum verum , the fruit of Illicium verum , and the flowers of Lavandula angustifolia are obtained by distillation.

可瞭解到的是,有關上述萃取方法的操作條件會進一步隨著所使用的植物的處理方式以及該植物的用量比例等因素而被變動,以便達致最佳的萃取效果。而這些操作條件的選擇可以依據已知技術進行調整及變化。 It can be understood that the operating conditions related to the above-mentioned extraction method will be further changed according to factors such as the treatment method of the plant used and the dosage ratio of the plant in order to achieve the best extraction effect. The selection of these operating conditions can be adjusted and changed according to known technologies.

本發明美白精油組成物的各成分含量可以依據實際使用進行調整,較佳地,以該美白精油組成物的總體積為100vol%,該美白精油組成物包含:15~30vol%的台灣扁柏精油、15~30vol%的紅檜精油、20~30vol%的錫蘭肉桂精油、10~30vol%的八角茴香精油以及10~30vol%的狹葉薰衣草精油。 The content of each component of the whitening essential oil composition of the present invention can be adjusted according to actual use. Preferably, the total volume of the whitening essential oil composition is 100 vol%, and the whitening essential oil composition includes: 15-30 vol% Taiwan cypress essential oil, 15~30vol% red juniper essential oil, 20~30vol% Ceylon cinnamon essential oil, 10~30vol% star anise essential oil, and 10~30vol% lavender essential oil.

依據本發明的美白精油組成物經由活體外試驗而被證實可以有效地抑制酪胺酸酶活性。據此,依據本發明的美白精油組 成物被預期具有促進皮膚美白的效用,因而可供應用於製備一用來美白皮膚之醫藥品或化妝品的用途。 The whitening essential oil composition according to the present invention has been confirmed through in vitro tests to effectively inhibit tyrosinase activity. Accordingly, the whitening essential oil group according to the present invention The product is expected to have the effect of promoting skin whitening, and therefore can be applied to the preparation of a medicine or cosmetics for skin whitening.

如本文中所用的,術語“美白(whitening)”與“膚色淡化(skin color lightening)”、“漂白(bleaching)”、“淨白”、“增白(brightening)”、“退黑”、“驅黑”、“淡化黑色素(lightening the melanin)”、“抑制黑色素生成(inhibition of melanogenesis)”以及“抑制黑色素合成(inhibition of melanin synthesis)”可被交換地使用。 As used herein, the terms "whitening" and "skin color lightening", "bleaching", "whitening", "brightening", "blackening", " "Inhibition of melanin", "lightening the melanin", "inhibition of melanogenesis" and "inhibition of melanin synthesis" can be used interchangeably.

依據本發明,該醫藥品可利用熟習此技藝者所詳知的技術而被製造成一適合於局部地(topically)投藥的劑型。 According to the present invention, the medicine can be manufactured into a dosage form suitable for topically administration using techniques well known to those skilled in the art.

依據本發明,該醫藥品可進一步包含有一被廣泛地使用於藥物製造技術之藥學上可接受的載劑(pharmaceutically acceptable carrier)。例如,該藥學上可接受的載劑可包含一或多種選自於下列的試劑:溶劑(solvent)、緩衝液(buffer)、乳化劑(emulsifier)、懸浮劑(suspending agent)、分解劑(decomposer)、崩解劑(disintegrating agent)、分散劑(dispersing agent)、黏結劑(binding agent)、賦形劑(excipient)、安定劑(stabilizing agent)、螯合劑(chelating agent)、稀釋劑(diluent)、膠凝劑(gelling agent)、防腐劑(preservative)、潤濕劑(wetting agent)、潤滑劑(lubricant)、吸 收延遲劑(absorption delaying agent)、脂質體(liposome)以及類似之物。有關這些試劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the drug may further include a pharmaceutically acceptable carrier widely used in drug manufacturing technology. For example, the pharmaceutically acceptable carrier may include one or more reagents selected from the group consisting of solvent, buffer, emulsifier, suspending agent, decomposer ), disintegrating agent, dispersing agent, binding agent, excipient, stabilizing agent, chelating agent, diluent , Gelling agent, preservative, wetting agent, lubricant, absorbent Absorption delaying agents, liposomes and the like. The selection and quantity of these reagents fall within the scope of professionalism and routine techniques of those who are familiar with this technique.

依據本發明,該醫藥品亦可利用熟習此技藝者所詳知的技術而被製造成一適合於局部地施用於皮膚上的外部製劑(external preparation),這包括,但不限於:乳劑(emulsion)、凝膠(gel)、軟膏(ointment)、乳霜(cream)、貼片(patch)、擦劑(liniment)、粉末(powder)、氣溶膠(aerosol)、噴霧(spray)、乳液(lotion)、乳漿(serum)、糊劑(paste)、泡沫(foam)、滴劑(drop)、懸浮液(suspension)、油膏(salve)、繃帶(bandage)以及油劑(oil)。 According to the present invention, the medicine can also be manufactured into an external preparation suitable for topical application to the skin by using techniques well known to those skilled in the art. This includes, but is not limited to: emulsions , Gel, ointment, cream, patch, liniment, powder, aerosol, spray, lotion , Serum, paste, foam, drop, suspension, salve, bandage and oil.

依據本發明,該外部製劑是藉由將該醫藥品與一為熟習此項技藝者所詳知的基底(base)相混合而被製備。 According to the present invention, the external preparation is prepared by mixing the medicine with a base well known to those skilled in the art.

依據本發明,該基底可包含有一或多種選自於下列的添加劑(additives):水、醇(alcohols)、甘醇(glycol)、碳氫化合物(hydrocarbons)[諸如石油膠(petroleum jelly)以及白凡士林(white petrolatum)]、蠟(wax)[諸如石蠟(paraffin)以及黃蠟(yellow wax)]、保存劑(preserving agents)、抗氧化劑(antioxidants)、界面活性劑(surfactants)、吸收增強劑(absorption enhancers)、安定劑(stabilizing agents)、膠凝劑(gelling agents)[諸如卡波普®974P(carbopol®974P)、微結晶纖 維素(microcrystalline cellulose)以及羧基甲基纖維素(carboxymethyl cellulose)]、活性劑(active agents)、保濕劑(humectants)、氣味吸收劑(odor absorbers)、香料(fragrances)、pH調整劑(pH adjusting agents)、螯合劑(chelating agents)、乳化劑(emulsifiers)、閉塞劑(occlusive agents)、軟化劑(emollients)、增稠劑(thickeners)、助溶劑(solubilizing agents)、滲透增強劑(penetration enhancers)、抗刺激劑(anti-irritants)、著色劑(colorants)以及推進劑(propellants)等。有關這些添加劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the substrate may contain one or more additives selected from the following: water, alcohols, glycols, hydrocarbons (such as petroleum jelly) and white Vaseline (white petrolatum), wax (such as paraffin and yellow wax), preserving agents, antioxidants, surfactants, absorption enhancers enhancers), stabilizers (stabilizing agents), gelling agent (gelling agents) [such as Carbopol ® 974P (carbopol ® 974P), microcrystalline cellulose (microcrystalline cellulose) and carboxymethyl cellulose (carboxymethyl cellulose)], Active agents, humectants, odor absorbers, fragrances, pH adjusting agents, chelating agents, emulsifiers, occlusive agents (occlusive agents), emollients, thickeners, solubilizing agents, penetration enhancers, anti-irritants, colorants and propellants (propellants) and so on. The selection and quantity of these additives fall within the scope of professionalism and routine technology of those who are familiar with this technology.

依據本發明,該化妝品可進一步包含有一被廣泛地使用於化妝品製造技術之化妝品上可接受的佐劑(cosmetically acceptable adjuvant)。例如,該化妝品上可接受的佐劑可包含有一或多種選自於下列的試劑:溶劑(solvent)、膠凝劑、活性劑、防腐劑(preservative)、抗氧化劑、遮蔽劑(screening agent)、螯合劑、界面活性劑、染色試劑(coloring agent)、增稠劑(thickening agent)、填料(filler)、香料以及氣味吸收劑。有關這些試劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the cosmetic may further include a cosmetically acceptable adjuvant which is widely used in cosmetic manufacturing technology. For example, the cosmetically acceptable adjuvant may contain one or more agents selected from the group consisting of solvents, gelling agents, active agents, preservatives, antioxidants, screening agents, Chelating agents, surfactants, coloring agents, thickening agents, fillers, fragrances and odor absorbers. The selection and quantity of these reagents fall within the scope of professionalism and routine techniques of those who are familiar with this technique.

依據本發明,該化妝品可利用熟習此技藝者所詳知的技術而被製造成一適合於護膚(skincare)或化妝(makeup)的形 式,這包括,但不限於:水性溶液(aqueous solution)、水-醇溶液(aqueous-alcohol solution)或油性溶液(oily solution)、呈水包油型(oil-in-water type)、油包水型(water-in-oil type)或複合型之乳劑、凝膠、軟膏、乳霜、面膜(mask)、貼片、貼布(pack)、擦劑、粉末、氣溶膠、噴霧、乳液、乳漿、糊劑、泡沫、分散液、滴劑、慕斯(mousse)、防曬油(sunblock)、化妝水(tonic water)、粉底(foundation)、眼影(eyeshadow)、卸妝產品(makeup remover products)、肥皂(soap)以及其他身體清潔產品(body cleansing products)等。 According to the present invention, the cosmetic can be made into a shape suitable for skincare or makeup by using techniques well known to those skilled in the art. Formula, this includes, but is not limited to: aqueous solution (aqueous solution), water-alcohol solution (aqueous-alcohol solution) or oily solution (oily solution), oil-in-water type, oil package Water-in-oil type or compound emulsion, gel, ointment, cream, mask, patch, pack, liniment, powder, aerosol, spray, lotion, Cream, paste, foam, dispersion, drops, mousse, sunblock, tonic water, foundation, eyeshadow, makeup remover products , Soap and other body cleansing products.

依據本發明,該化妝品亦可與一或多種選自於下列之已知活性的外用劑(external use agents)一起合併使用:美白劑(whitening agents)[諸如維生素A酸(tretinoin)、兒茶素(catechin)、麴酸、熊果苷以及維生素C]、保濕劑、抗發炎劑(anti-inflammatory agents)、殺菌劑(bactericides)、紫外線吸收劑(ultraviolet absorbers)、植物萃取物(plant extracts)[諸如蘆薈萃取物(aloe extract)]、皮膚營養劑(skin nutrients)、麻醉劑(anesthetics)、抗痘劑(anti-acne agent)、止癢劑(antipruritic)、止痛劑(analgesic)、抗皮膚炎劑(antidermatitis agents)、抗過角化劑(antihyperkeratolytic agents)、抗乾皮膚劑(anti-dry skin agents)、抗乾癬劑(antipsoriatic agents)、抗老化劑(antiaging agents)、抗皺劑(antiwrinkle agents)、抗皮脂溢出劑(antiseborrheic agents)、傷口治療劑(wound-healing agents)、皮質類固醇(corticosteroids)以及激素(hormones)。有關這些外用劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the cosmetic can also be used in combination with one or more external use agents with known activity selected from the following: whitening agents (such as tretinoin, catechins) (catechin), kojic acid, arbutin and vitamin C], moisturizers, anti-inflammatory agents, bactericides, ultraviolet absorbers, plant extracts [ Such as aloe extract, skin nutrients, anesthetics, anti-acne agents, antipruritic, analgesic, and anti-dermatitis agents (antidermatitis agents), antihyperkeratolytic agents, anti-dry skin agents, antipsoriatic agents, antiaging agents agents, antiwrinkle agents, antiseborrheic agents, wound-healing agents, corticosteroids and hormones. The selection and quantity of these topical agents fall within the scope of professionalism and routine techniques of those who are familiar with this technique.

本發明亦提供一種用於美白皮膚的方法,其包括對一需要促進皮膚美白的個體投予本發明的美白精油組成物。較佳地,該方法包括對該個體的皮膚施用一有效量的美白精油組成物,並且歷時一足夠的時間直到皮膚的黑色素被顯著地淡化。 The present invention also provides a method for whitening skin, which comprises administering the whitening essential oil composition of the present invention to an individual who needs to promote skin whitening. Preferably, the method includes applying an effective amount of the whitening essential oil composition to the skin of the individual, and for a sufficient time until the melanin of the skin is significantly reduced.

如本文中所用的,術語“投予(administering)”與“投藥”以及“施用(application)”可被交換地使用。 As used herein, the terms "administering" and "administering" and "application" can be used interchangeably.

如此處所用的,術語“有效量(effective amount)”意指當本發明的美白精油組成物被投予一需要促進皮膚美白的個體時,一足以提供所欲達致之美白功效並且不會對皮膚產生非所欲的不利副作用的安全用量。 As used herein, the term "effective amount" means that when the whitening essential oil composition of the present invention is administered to an individual who needs to promote skin whitening, it is sufficient to provide the desired whitening effect and will not be harmful A safe dosage for undesirable adverse side effects to the skin.

如此處所用的,術語“有效量”與“有效劑量(effective dose)”、“美白有效量(whitening effective amount)”以及“美白有效劑量(whitening effective dose)”可被交換地使用。 As used herein, the terms "effective amount" and "effective dose", "whitening effective amount" and "whitening effective dose" can be used interchangeably.

依據本發明,該美白精油組成物的有效量與施用頻率(frequency of application)會視下列因素而變化:要被淡化黑色 素的皮膚區域之初始病況(initial condition)以及所欲達致之最終的美白效果。一般而言,當依據本發明的美白精油組成物被局部地施用於皮膚上時,每次施用的有效量通常是5至10mg/平方公分的皮膚面積,每天大約1至2次。 According to the present invention, the effective amount and frequency of application of the whitening essential oil composition will vary depending on the following factors: to be lightened black The initial condition of the skin area and the desired final whitening effect. Generally speaking, when the whitening essential oil composition according to the present invention is topically applied to the skin, the effective amount per application is usually 5 to 10 mg/cm² of skin area, about 1 to 2 times a day.

本發明將就下面的實施例來做進一步說明,但應瞭解的是,該等實施例僅是供例示說明用,而不應被解釋為本發明的實施上的限制。 The present invention will be further described with the following embodiments, but it should be understood that these embodiments are for illustrative purposes only, and should not be interpreted as limitations on the implementation of the present invention.

一般實驗方法:General experimental method: 1.統計學分析(statistical analysis): 1. Statistical analysis:

在下面的實施例中,所有的實驗數據是以“平均值(mean)±標準差(standard deviation,SD)”來表示。 In the following examples, all experimental data are expressed as "mean ± standard deviation (SD)".

<實施例1-4>本發明美白精油組成物的製備<Example 1-4> Preparation of the whitening essential oil composition of the present invention

在下面用來製備本發明美白精油組成物的各個單方精油包括:1.台灣扁柏(Chamaecyparis obtusa var.formosana)精油,購自於百冠生化科技股份有限公司(商品名稱:台灣檜木精油),濃度1000ppm;2.紅檜(Chamaecyparis formosensis)精油,購自於德麗興業社(商品名稱:台灣紅檜精油),濃度1000ppm; 3.八角茴香(Illicium verum)精油,購自於FPI SALES TAIWAN(商品名稱:八角茴香純精油),濃度1000ppm;4.錫蘭肉桂(Cinnamomum verum)精油,購自於Sydney Essential Oil Co.(商品名稱:Cinnamon Bark Oil),濃度1000ppm;以及5.狹葉薰衣草(Lavandula angustifolia)精油,購自於Sydney Essential Oil Co.[商品名稱:Lavender Oil(Bulgaria)],濃度1000ppm。 The individual essential oils used to prepare the whitening essential oil composition of the present invention below include: 1. Taiwan cypress ( Chamaecyparis obtusa var. formosana ) essential oil, purchased from Baiguan Biochemical Technology Co., Ltd. (trade name: Taiwan cypress essential oil), concentration 1000ppm; 2. Red cypress ( Chamaecyparis formosensis ) essential oil, purchased from Deli Industrial Co., Ltd. (trade name: Taiwan red cypress essential oil), with a concentration of 1000ppm; 3. Illicium verum (Illicium verum) essential oil, purchased from FPI SALES TAIWAN (commodity) Name: star anise pure essential oil, concentration 1000ppm; 4. Cinnamomum verum essential oil, purchased from Sydney Essential Oil Co. (trade name: Cinnamon Bark Oil), concentration 1000ppm; and 5. Lavandula angustifolia ) essential oil, purchased from Sydney Essential Oil Co. [trade name: Lavender Oil (Bulgaria)], with a concentration of 1000 ppm.

將上述5種單方精油依據下面表1所示的配方來進行混合,而得到實施例1至4的美白精油組成物。 The above 5 kinds of single essential oils were mixed according to the formula shown in Table 1 below to obtain the whitening essential oil compositions of Examples 1 to 4.

Figure 109114049-A0305-02-0012-1
Figure 109114049-A0305-02-0012-1

<比較例1-5>單方精油<Comparative Example 1-5> Single Essential Oil

為供比較,申請人將用於製備實施例1至4的台灣扁柏精油、紅檜精油、錫蘭肉桂精油、八角茴香精油以及狹葉薰衣草精油共5種單方精油分別作為比較例1至5。 For comparison, the applicant used the five single essential oils of Taiwan cypress essential oil, red cypress essential oil, Ceylon cinnamon essential oil, star anise essential oil, and lavender essential oil used in the preparation of Examples 1 to 4 as Comparative Examples 1 to 5, respectively.

<比較例6-8>對照精油組成物<Comparative Example 6-8> Control Essential Oil Composition

另外依據下表2的精油種類及含量進行比較例6至8的調配,以得到比較例6至8的對照精油組成物。 In addition, the formulations of Comparative Examples 6 to 8 were performed according to the types and contents of the essential oils in Table 2 below to obtain the control essential oil compositions of Comparative Examples 6 to 8.

Figure 109114049-A0305-02-0013-2
「-」表示未添加,含量為0vol%。
Figure 109114049-A0305-02-0013-2
"-" means no addition, and the content is 0vol%.

<測試>抑制酪胺酸酶活性(tyrosinase activity)能力的測定<Test> Determination of the ability to inhibit tyrosinase activity

接著,申請人藉由測定上述實施例1至4的酪胺酸酶活性(tyrosinase activity)來評估本發明的美白精油組成物在抑制黑色素生成上的效用。此外,為供比對,比較例1至8亦被拿來進行相同的實驗。 Next, the applicant evaluated the effectiveness of the whitening essential oil composition of the present invention in inhibiting melanin production by measuring the tyrosinase activity of the above-mentioned Examples 1 to 4. In addition, for comparison, Comparative Examples 1 to 8 were also used for the same experiment.

測試方法:首先,將4.556g的磷酸二氫鉀(monopotassium phosphate)以及4.757g的磷酸氫二鈉(Sodium hydrogen phosphate)分別溶於500mL的去離子水中,繼而予以混合均勻,而得到一pH值6.8的67mM磷酸鹽緩衝溶液(phosphate buffer solution)。接著,將50U的酪胺酸酶(L-tyrosine)(購自於 友和貿易股份有限公司)添加至適量的磷酸鹽緩衝溶液中,而得到一濃度為50U/mL的酪胺酸酶溶液。 Test method: First, dissolve 4.556 g of monopotassium phosphate and 4.757 g of sodium hydrogen phosphate in 500 mL of deionized water, and then mix them uniformly to obtain a pH of 6.8 67mM phosphate buffer solution (phosphate buffer solution). Next, 50U of tyrosine (L-tyrosine) (purchased from Youhe Trading Co., Ltd.) was added to an appropriate amount of phosphate buffer solution to obtain a tyrosinase solution with a concentration of 50 U/mL.

之後,將實施例1至4以及比較例1至8之單方精油與精油組成物分別與Tween-20(購自於台灣默克股份有限公司)以一為1:8(v/v)的比例混合均勻,繼而添加適量的磷酸鹽緩衝溶液,而使得各單方精油與精油組成物的終濃度為1000ppm。接著,對稀釋至1000ppm的實施例1至4之精油組成物以及比較例1至8之單方精油與精油組成物各取50μL,分別添加以120μL的2.5mM L-3,4-二羥苯丙氨酸(L-3,4-dihydroxyphenylalanine,L-DOPA)(購自於友和貿易股份有限公司)(配於磷酸鹽緩衝溶液中),以及100μL的酪胺酸酶溶液並予以混合均勻,所形成的混合物被置於37℃下進行避光作用歷時30分鐘,然後於475nm的波長下以分光光度計來量測吸光值(OD475)。另外,將0.08g的Tween-20溶於10mL的磷酸鹽緩衝溶液中以作為空白對照組來進行相同的實驗。若所測得的吸光值(OD475)越低,代表抑制酪胺酸酶活性的能力越佳。 After that, the single essential oils and essential oil compositions of Examples 1 to 4 and Comparative Examples 1 to 8 and Tween-20 (purchased from Taiwan Merck Co., Ltd.) were set at a ratio of 1:8 (v/v). Mix well, and then add an appropriate amount of phosphate buffer solution, so that the final concentration of each single essential oil and essential oil composition is 1000 ppm. Next, take 50 μL of the essential oil composition of Examples 1 to 4 and the single essential oil and essential oil composition of Comparative Examples 1 to 8 diluted to 1000 ppm, and add 120 μL of 2.5 mM L-3,4-dihydroxyphenylpropane respectively. L-3,4-dihydroxyphenylalanine (L-DOPA) (purchased from Youhe Trading Co., Ltd.) (prepared in phosphate buffer solution), and 100μL of tyrosinase solution and mixed uniformly to form The mixture was placed at 37°C for light protection for 30 minutes, and then the absorbance (OD 475 ) was measured with a spectrophotometer at a wavelength of 475 nm. In addition, 0.08 g of Tween-20 was dissolved in 10 mL of phosphate buffer solution as a blank control group to perform the same experiment. If the measured absorbance value (OD 475 ) is lower, it means that the ability to inhibit tyrosinase activity is better.

酪胺酸酶活性抑制率(%)是藉由將所測得的吸光值(OD475)代入下列公式(I)而被計算出:A=[1-(B/C)]×100 (I) Tyrosinase activity inhibition rate (%) is calculated by substituting the measured absorbance value (OD 475 ) into the following formula (I): A=[1-(B/C)]×100 (I )

其中:A=酪胺酸酶活性抑制率(%) Among them: A = Inhibition rate of tyrosinase activity (%)

B=各個實施例或比較例所測得的OD475吸光值 B = OD 475 absorbance measured in each embodiment or comparative example

C=空白對照組所測得的OD475吸光值 C= OD 475 absorbance measured by the blank control group

有關實施例1至4以及比較例6至8的預期抑制率(%)是以比較例1至5的單方精油所測得之酪胺酸酶活性抑制率以及該等單方精油在實施例1至4中的含量計算而得。 The expected inhibition rate (%) of the relevant Examples 1 to 4 and Comparative Examples 6 to 8 is the tyrosinase activity inhibition rate measured by the single essential oils of Comparative Examples 1 to 5 and the single essential oils in Examples 1 to 5 Calculated from the content in 4.

之後,依照上面“一般實驗方法”的第1項「統計學分析」當中所述的方法來分析所得到的實驗數據。所得到的結果分別顯示於下面的表3、表4以及表5。 After that, analyze the experimental data obtained in accordance with the method described in the first item "Statistical Analysis" of the "General Experimental Methods" above. The results obtained are shown in Table 3, Table 4, and Table 5 below, respectively.

Figure 109114049-A0305-02-0015-3
Figure 109114049-A0305-02-0015-3

Figure 109114049-A0305-02-0016-4
Figure 109114049-A0305-02-0016-4

Figure 109114049-A0305-02-0016-5
Figure 109114049-A0305-02-0016-5

從表3與表4可見,比較例1至5之單方精油的酪胺酸酶活性抑制率大約落在29%至53%,而其中又以比較例1的台灣扁柏精油具有最高的酪胺酸酶活性抑制率(52.62±1.46%)。另一方面,實施例1至4之美白精油組成物的酪胺酸酶活性抑制率大約落在57%至63%,皆高於比較例1至5之抑制率。而且實施例1至4實際測得的酪胺酸酶活性抑制率更是遠高於其預期抑制率,其差異達約14.0%至 18.3%,顯示實施例1至4的結果無法由比較例1至5的功效單純疊加所達成,同時證明本發明美白精油組成物可有效抑制酪胺酸酶活性,進而抑制黑色素生成。 From Table 3 and Table 4, it can be seen that the tyrosinase activity inhibition rate of the single essential oils of Comparative Examples 1 to 5 is about 29% to 53%, and among them, the essential oil of Taiwan Cypress of Comparative Example 1 has the highest tyrosine. Enzyme activity inhibition rate (52.62±1.46%). On the other hand, the inhibition rate of tyrosinase activity of the whitening essential oil composition of Examples 1 to 4 is about 57% to 63%, which is higher than that of Comparative Examples 1 to 5. Moreover, the inhibition rate of tyrosinase activity actually measured in Examples 1 to 4 is much higher than its expected inhibition rate, with a difference of about 14.0% to 18.3%, showing that the results of Examples 1 to 4 cannot be achieved by simply superimposing the effects of Comparative Examples 1 to 5, and it also proves that the whitening essential oil composition of the present invention can effectively inhibit tyrosinase activity, thereby inhibiting melanin production.

從表4與表5可見,比較例6至8的酪胺酸酶活性抑制率大約落在45%至51%,皆低於實施例1至4之抑制率,而相較於對應的預期抑制率,比較例6至8之抑制率亦無顯著的提升。其中,選用台灣扁柏精油、紅檜精油、錫蘭肉桂精油以及八角茴香精油混合所得到的比較例7,以及選用台灣扁柏精油、紅檜精油、八角茴香精油以及狹葉薰衣草精油混合所得到的比較例8,其實際測得的酪胺酸酶活性抑制率相較於其預期抑制率僅微幅增加;特別地,選用酪胺酸酶活性抑制率較高(45%以上)的台灣扁柏精油、紅檜精油與錫蘭肉桂精油混合所得到的比較例6,其實際測得的酪胺酸酶活性抑制率甚至低於其預期抑制率,顯示本發明的實施例1至4的結果並非透過比較例1至5之簡單置換或組合所能達成的,更證明本發明美白精油組成物必須同時含有台灣扁柏精油、紅檜精油、錫蘭肉桂精油、八角茴香精油以及狹葉薰衣草精油。 It can be seen from Table 4 and Table 5 that the inhibition rate of tyrosinase activity of Comparative Examples 6 to 8 is about 45% to 51%, which are all lower than the inhibition rate of Examples 1 to 4, and compared to the corresponding expected inhibition rate. The inhibition rate of Comparative Examples 6 to 8 also did not increase significantly. Among them, comparative example 7 obtained by mixing Taiwan cypress essential oil, red cypress essential oil, Ceylon cinnamon essential oil, and star anise essential oil, and a comparison obtained by mixing Taiwan cypress essential oil, red cypress essential oil, star anise essential oil, and lavender essential oil In Example 8, the actually measured inhibition rate of tyrosinase activity was only slightly increased compared to its expected inhibition rate; in particular, the Taiwan cypress essential oil, which has a higher inhibition rate of tyrosinase activity (above 45%), was selected. In Comparative Example 6 obtained by mixing red juniper essential oil and Ceylon cinnamon essential oil, the actually measured inhibition rate of tyrosinase activity was even lower than its expected inhibition rate, showing that the results of Examples 1 to 4 of the present invention are not through comparison What can be achieved by the simple replacement or combination of Examples 1 to 5 further proves that the whitening essential oil composition of the present invention must contain Taiwan cypress essential oil, red cypress essential oil, Ceylon cinnamon essential oil, star anise essential oil and lavender essential oil at the same time.

綜上所述,依據本發明的美白精油組成物因含有特定植物精油組合,而能有效抑制酪胺酸酶活性,進而達到抑制黑色素生成以及促進皮膚美白的功用。由前述也證明本發明的美白精油組 成物具有發展成為一黑色素生成抑制劑(melanogenesis inhibitor)(亦即皮膚美白劑)的高潛力。 In summary, the whitening essential oil composition according to the present invention can effectively inhibit the activity of tyrosinase due to the combination of specific plant essential oils, thereby achieving the functions of inhibiting melanin production and promoting skin whitening. It is also proved by the foregoing that the whitening essential oil group of the present invention The product has high potential to develop into a melanogenesis inhibitor (ie, skin whitening agent).

於本說明書中被引述之所有專利和文獻以其整體被併入本案作為參考資料。若有所衝突時,本案詳細說明(包含界定在內)將佔上風。 All patents and documents cited in this specification are incorporated into this case as reference materials in their entirety. If there is a conflict, the detailed description of the case (including the definition) will prevail.

雖然本發明已參考上述特定的具體例被描述,明顯地在不背離本發明之範圍和精神之下可作出很多的修改和變化。因此意欲的是,本發明僅受如隨文檢附之申請專利範圍所示者之限制。 Although the present invention has been described with reference to the above specific specific examples, it is obvious that many modifications and changes can be made without departing from the scope and spirit of the present invention. Therefore, it is intended that the present invention is only limited by the scope of the patent application attached hereto.

Claims (3)

一種美白精油組成物,包含:台灣扁柏精油、紅檜精油、錫蘭肉桂精油、八角茴香精油,以及狹葉薰衣草精油;其中,以該美白精油組成物的總體積為100vol%,該美白精油組成物包含:15~30vol%的台灣扁柏精油;15~30vol%的紅檜精油;20~30vol%的錫蘭肉桂精油;10~30vol%的八角茴香精油;以及10~30vol%的狹葉薰衣草精油。 A whitening essential oil composition comprising: Taiwan cypress essential oil, red cypress essential oil, Ceylon cinnamon essential oil, star anise essential oil, and anise lavender essential oil; wherein the total volume of the whitening essential oil composition is 100 vol%, and the whitening essential oil is composed of Contains: 15~30vol% Taiwan cypress essential oil; 15~30vol% red cypress essential oil; 20~30vol% Ceylon cinnamon essential oil; 10~30vol% star anise essential oil; and 10~30vol% lavender essential oil . 如請求項1的美白精油組成物,其進一步包含有一藥學上可接受的載劑或一化妝品上可接受的佐劑。 The whitening essential oil composition of claim 1, which further comprises a pharmaceutically acceptable carrier or a cosmetically acceptable adjuvant. 一種如請求項1至2中任一項的美白精油組成物供應用於製備一用來美白皮膚之醫藥品或化妝品的用途。 A whitening essential oil composition as claimed in any one of Claims 1 to 2 is supplied for use in the preparation of a medicine or cosmetic for skin whitening.
TW109114049A 2020-04-27 2020-04-27 Whitening essential oil composition and its use TWI748424B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW109114049A TWI748424B (en) 2020-04-27 2020-04-27 Whitening essential oil composition and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109114049A TWI748424B (en) 2020-04-27 2020-04-27 Whitening essential oil composition and its use

Publications (2)

Publication Number Publication Date
TW202139971A TW202139971A (en) 2021-11-01
TWI748424B true TWI748424B (en) 2021-12-01

Family

ID=80680923

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109114049A TWI748424B (en) 2020-04-27 2020-04-27 Whitening essential oil composition and its use

Country Status (1)

Country Link
TW (1) TWI748424B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11302149A (en) * 1998-04-15 1999-11-02 Pola Chem Ind Inc Melanin production inhibitor and external preparation for skin containing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11302149A (en) * 1998-04-15 1999-11-02 Pola Chem Ind Inc Melanin production inhibitor and external preparation for skin containing the same

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Chih-Chien Lin,et al." Antimicrobial, anti-tyrosinase and antioxidant activities of aqueous aromatic extracts from forty-eight selected herbs.", Journal of Medicinal Plants Research. 16 November, 2011, 5(26) :6203-6209. *
Chin-Hui Chen,et al."Antioxidant activity of some plant extracts towards xanthine oxidase, lipoxygenase and tyrosinase.",Molecules. 2009 Aug 10;14(8):2947-2958.
Chin-Hui Chen,et al."Antioxidant activity of some plant extracts towards xanthine oxidase, lipoxygenase and tyrosinase.",Molecules. 2009 Aug 10;14(8):2947-2958.; *
Su-Tze Chou,et al. Cinnamomum cassia essential oil inhibits α-MSH-induced melanin production and oxidative stress in murine B16 melanoma cells.", Int. J. Mol. Sci. 2013, 14, 19186-19201.
Su-Tze Chou,et al. Cinnamomum cassia essential oil inhibits α-MSH-induced melanin production and oxidative stress in murine B16 melanoma cells.", Int. J. Mol. Sci. 2013, 14, 19186-19201.; *

Also Published As

Publication number Publication date
TW202139971A (en) 2021-11-01

Similar Documents

Publication Publication Date Title
EP2482809B1 (en) Compositions comprising an anti-inflammatory blend
US20210093539A1 (en) Topical cosmetic
RU2562140C2 (en) Composition and method of treating signs of skin aging
EP2319488B1 (en) Compositions comprising an NFkB-inhibitor and a tropoelastin promoter
US20080199489A1 (en) Skin treatment formulations and method
JP2003113069A (en) External preparation for skin having acnegenic tendency
WO2007004229A2 (en) Methods of using pomegranate fractions for skin repair
KR101382112B1 (en) Composition of skin external application containing Chamaecyparis obtusa polysaccharide
JP2007077146A (en) Composition for controlling or reducing skin inflammation
DE202012005442U1 (en) Cosmetic composition
KR100782600B1 (en) Cosmetic compositions for anti-aging of skin comprising diosgenin and dioscin
TW201420127A (en) Extract of Phalaenopsis amabilis meristem, and the preparation process and uses thereof
TW201420107A (en) Extract of Phalaenopsis amabilis petals, and the preparation process and uses thereof
US20170196797A1 (en) Composition containing glycine gracilis oil
TWI748424B (en) Whitening essential oil composition and its use
EP3801778B1 (en) Use of a bixa orellana extract
JP2011236156A (en) Collagen production promoter
TW201420128A (en) Extract of Phalaenopsis amabilis embryo, and the preparation process and uses thereof
TWI635873B (en) Hydrolysate of water extract ofsyzygium samarangense, and the preparation process and uses thereof
JP3432175B2 (en) Cell growth promotion cosmetics
CN113662888B (en) Whitening essential oil composition and application thereof
JPH11100324A (en) Composition for treating pimple
Ong et al. 40 Skin whitening agents
TWI767168B (en) Use of rosa plant extract for improving mitochondrial activity
CN114432210A (en) Skin whitening and moisturizing composition containing glutathione and preparation method thereof